avelumab
Showing 26 - 50 of 171
Glioblastoma, GBM Trial in New York (Avelumab, MRI-guided LITT therapy)
Completed
- Glioblastoma
- GBM
- Avelumab
- MRI-guided LITT therapy
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Dec 31, 2021
Clear-cell Renal Cell Carcinoma, RCC, Kidney Cancer Trial in Birmingham (Avelumab, Sunitinib)
Withdrawn
- Clear-cell Renal Cell Carcinoma
- +3 more
- Avelumab
- Sunitinib
-
Birmingham, AlabamaUniversity of Alabama Hematology Oncology Clinic at Medical West
Feb 14, 2022
Melanoma, Head and Neck Squamous Cell Carcinoma Trial in Helsinki (TILT-123, Avelumab)
Recruiting
- Melanoma
- Head and Neck Squamous Cell Carcinoma
- TILT-123
- Avelumab
-
Helsinki, FinlandDocrates Cancer Center
Jul 12, 2022
Penile Cancer, Penile Tumors, Penile Squamous Cell Carcinoma Trial in Besançon (Avelumab)
Recruiting
- Penile Cancer
- +2 more
- Avelumab
-
Besançon, FranceAntoine THIERY VUILLEMIN
Feb 23, 2022
OBSERVATIONAL STUDY OF AVELUMAB AS FIRST-LINE MAINTENANCE
Recruiting
- Urothelial Cancer
- Avelumab
-
Bristol, United Kingdom
- +9 more
Jan 23, 2023
CNS Tumors Trial in Worldwide (Avelumab, Lenvatinib)
Recruiting
- Central Nervous System Tumors
- Avelumab
- Lenvatinib
-
Saint Louis, Missouri
- +9 more
Jul 21, 2022
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Gyeonggi-do, Seoul (GEN-001, Avelumab)
Recruiting
- Gastric Cancer
- Gastroesophageal Junction Adenocarcinoma
- GEN-001
- Avelumab
-
Gyeonggi-do, Korea, Republic of
- +4 more
Jun 14, 2022
Non Small Cell Lung Cancer Trial in Nijmegen (89Zr-avelumab PET, Avelumab)
Completed
- Non Small Cell Lung Cancer
- 89Zr-avelumab PET
- Avelumab
-
Nijmegen, NetherlandsRadboud University
Jan 6, 2022
Breast Cancer Trial in United States (Avelumab, Endocrine therapy, Palbociclib)
Recruiting
- Breast Cancer
- Avelumab
- +2 more
-
Birmingham, Alabama
- +3 more
Apr 15, 2022
Urothelial Carcinoma Trial (Avelumab)
Not yet recruiting
- Urothelial Carcinoma
- Avelumab
- (no location specified)
Oct 26, 2022
Penile Cancer, Advanced Cancer, Metastatic Cancer Trial in Toronto (Avelumab, Best Supportive Care)
Recruiting
- Penile Cancer
- +2 more
- Avelumab
- Best Supportive Care
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Nov 26, 2021
Malignant Mesothelioma (MPM) Trial in United States (Avelumab, Stereotactic Body Radiation Therapy)
Active, not recruiting
- Malignant Mesothelioma (MPM)
- Avelumab
- Stereotactic Body Radiation Therapy
-
Basking Ridge, New Jersey
- +6 more
Mar 7, 2022
Stage III Merkel Cell Carcinoma AJCC v8, Stage IIIB Merkel Cell Carcinoma AJCC v8, Stage IIIA Merkel Cell Carcinoma AJCC v8
Recruiting
- Stage III Merkel Cell Carcinoma AJCC v8
- +2 more
- Avelumab
- +2 more
-
Orange, California
- +10 more
Jan 30, 2023
Triple Negative Breast Cancer, Locally Advanced Breast Cancer, Recurrent Breast Cancer Trial in London (Palbociclib, Avelumab)
Recruiting
- Triple Negative Breast Cancer
- +5 more
- Palbociclib
- Avelumab
-
Manchester, Greater Manchester, United Kingdom
- +6 more
Jan 5, 2023
Cancer Trial in Germany (Avelumab)
Completed
- Cancer
- Avelumab
-
Halle (Saale), Germany
- +3 more
Feb 24, 2022
T-Cell Lymphoma Relapsed, T-Cell Lymphoma Refractory Trial in London (Avelumab)
Completed
- T-Cell Lymphoma Relapsed
- T-Cell Lymphoma Refractory
- Avelumab
-
London, United KingdomUniversity College London Hospital
Oct 1, 2021
SOGUG-AVELUMAB_RWD
Recruiting
- Metastatic Urothelial Carcinoma
- Avelumab
-
Vigo, Pontevedra, Spain
- +21 more
Jan 17, 2023
Lymphoma, Extranodal NK-T-Cell Trial in Seoul (avelumab)
Active, not recruiting
- Lymphoma, Extranodal NK-T-Cell
- avelumab
-
Seoul, Korea, Republic of81, Irwon-ro, Gangnam-gu, Seoul, Republic of Korea
Sep 22, 2021
Metastatic sRCC Trial in Philadelphia (Avelumab, Gemcitabine)
Recruiting
- Metastatic sRCC
- Avelumab
- Gemcitabine
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Jul 22, 2021
Learn About First-line Avelumab Maintenance in Japanese Locally
Not yet recruiting
- Urothelial Carcinoma
- Avelumab
-
Nagoya, Aichi, Japan
- +14 more
Jul 21, 2022
Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant, Infiltrating Bladder Urothelial Carcinoma With Glandular
Recruiting
- Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant
- +6 more
- Avelumab
- Pemetrexed
-
Houston, TexasM D Anderson Cancer Center
Nov 17, 2021
Small Cell Lung Carcinoma Trial in Greece (Avelumab)
Active, not recruiting
- Small Cell Lung Carcinoma
- Avelumab
-
Chaïdári, Athens, Greece
- +5 more
Apr 18, 2022